ARCHIVES

DCE Reorganization Planned To Stem Departures, Stabilize

This article is from The Cancer Letter archive.

Vol. 21 No. 12 | March 24, 1995

Download PDF Visit The Full Archive

Related Articles

Shaw’s Lung Cancer, Bronchoalveolar Carcinoma, Exemplifies Elusiveness of 2015 Goal. Little Known About The Rare Disease.

February 3, 2006

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

Agency Approves Two Pairs Of Drugs and Diagnostic Tests

September 30, 2011

Cancer Epidemiology Hampered By Bureaucratic Delays, Lack of Cooperation, NCI Group Says

September 29, 1978

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

April 11, 2003